Novartis completed about $25 billion of transactions in its product portfolios, including the sale of two units to British-based ...
Pharmaceutical giant Novartis is celebrating its 20th birthday, and analysts say it is a big success. But the company has had its fair ...
Vas Narasimhan, Novartis CEO, joins 'Squawk on the Street' to discuss the company's positive Leukemia drug results, the review ...
YouTube
- 7 days ago
Vas Narasimhan, CEO of Novartis, says the pharmaceutical company does not plan to follow competitors in entering into the ...
Pat Keller of Novartis Pharma AG discusses how the Innovation Masters Series taught him the importance of redefining rules and ...
Our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of ...
YouTube
- 10 years ago
There has been a major shake-up in the drugmaking world. Swiss firm Novartis is selling its animal medicines division and ...
At Novartis, we're pushing the boundaries of science to reimagine medicine for patients. Our teams work across multiple ...
One of the world's leading medicines companies, Novartis is discovering and developing novel, high-value medicines to address ...
YouTube
- 6 years ago
Sheeram Aradhye, Chief Medical Officer, Global Head of Medical Affairs, Pharmaceuticals, Novartis speaking at eyeforpharma ...